Amalgamated Bank’s BioAtla BCAB Stock Holding History

Amalgamated Bank’s Portfolio BCAB Stock Details BCAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-30	Closed	-$5K	–	3015
2024 Q1	$5K	Sell	30 -47	-61%	-$5.84K	﹤0.01%	2693
2023 Q4	$9K	Sell	77 -9	-10%	-$780	﹤0.01%	2869
2023 Q3	$7K	Hold	86	–	–	﹤0.01%	2944
2023 Q2	$13K	Buy	+86	New	+$14.8K	﹤0.01%	2900
2022 Q2	–	Sell	-51	Closed	-$13K	–	3044
2022 Q1	$13K	Buy	+51	New	+$21.3K	﹤0.01%	2909

Other funds holding BCAB

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

SAM

Scion Asset Management Saratoga, California $1.38B AUM 43.96% 1-Year Est. Return

Amalgamated Bank's BCAB Position: Q2 2024 in Review

Amalgamated Bank sold out of BioAtla (BCAB) in Q2 2024, closing a stake of 30 shares — an estimated $5K sold.

Amalgamated Bank first reported a position in BCAB in Q1 2022 and held it in 5 quarters. The position peaked at $13K in Q2 2023. 80 funds tracked by Wall St. Rank hold BCAB as of Q2 2024.

Amalgamated Bank reported no remaining BioAtla position as of Q2 2024 after selling out during the quarter.
Amalgamated Bank sold 30 BioAtla shares in Q2 2024, an estimated $5K.
Amalgamated Bank first reported a position in BioAtla in Q1 2022 and held it in 5 quarters.
Amalgamated Bank's BioAtla position peaked at $13K in Q2 2023.
80 funds tracked by Wall St. Rank held BioAtla as of Q2 2024.

Based on Amalgamated Bank's 13F filing for Q2 2024, filed 12 Aug 2024.